RESEARCH AND DEVELOPMENT COSTS AND RETURNS - US PHARMACEUTICAL INDUSTRY

被引：47

作者：

BAILY, MN ^{[1
]}

机构：

[1] MIT,CAMBRIDGE,MA

来源：

关键词：

D O I：

10.1086/259862

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：70 / 85

页数：16

共 34 条

[1] ARNOW LE, 1970, HEALTH BOTTLE
[2] Arrow K. J., 1962, RATE DIRECTION INVEN, DOI DOI 10.1521/IJGP.2006.56.2.191
[3] OPTIMAL TIMING OF INNOVATIONS
BARZEL, Y
[J]. REVIEW OF ECONOMICS AND STATISTICS, 1968, 50 (03) : 348 - 355
[4] BEYER KH, 1964, CLIN PHARMACOL THER, V5, P1
[5] BURLINGHAM R, 1951, ODYSSEY MODERN DRUG
[6] BURNS JJ, 1969, 1 SEM EC PHARM INN
[7] *CAN RESTR PARACT, 1963, REP CONC MAN DISTR S
[8] CLYMER HA, 1969, 1 SEM EC PHARM INN
[9] PATENT STATISTICS AS A MEASURE OF TECHNICAL CHANGE
COMANOR, WS
SCHERER, FM
[J]. JOURNAL OF POLITICAL ECONOMY, 1969, 77 (03) : 392 - 398
[10] RESEARCH AND TECHNICAL CHANGE IN THE PHARMACEUTICAL-INDUSTRY
COMANOR, WS
[J]. REVIEW OF ECONOMICS AND STATISTICS, 1965, 47 (02) : 182 - 190